The University of Chicago Header Logo

Connection

Scott E. Eggener to Abiraterone Acetate

Back to Details
This is a "connection" page, showing publications Scott E. Eggener has written about Abiraterone Acetate.
Scott E. Eggener
Connection Strength
0.059
Abiraterone Acetate
  1. PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19). J Clin Oncol. 2024 Apr 01; 42(10):1114-1123.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.